References
- Rai A, Nastoupil LJ, Williams JN, et al. Patterns of use and survival outcomes of positron emission tomography for initial staging in elderly follicular lymphoma patients. Luek Lymphoma. 2017;58:1570–1580.
- Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32:3059–3068.
- Hofman MS, Hicks RJ. Imaging in follicular NHL. Best Pract Res Clin Haematol. 2011;24:165–177.
- Barrington SF, Mikhaeel NG, Kostakoglu L, et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol. 2014;32:3048–3058.
- Hofman MS, Smeeton NC, Rankin SC, et al. Observer variation in interpreting 18F-FDG PET/CT findings for lymphoma staging. J Nucl Med. 2009;50:1594–1597.
- Wirth A, Foo M, Seymour JF, et al. Impact of [18F] fluorodeoxyglucose positron emission tomography on staging and management of early-stage follicular non-Hodgkin lymphoma. Int J Radiat Oncol Biol Phys. 2008;71:213–219.
- Scott AM, Gunawardana DH, Wong J, et al. Positron emission tomography changes management, improves prognostic stratification and is superior to gallium scintigraphy in patients with low-grade lymphoma: results of a multicentre prospective study. Eur J Nucl Med Mol Imaging. 2009;36:347–353.
- Sackett DL, Clinical epidemiology: a basic science for clinical medicine. Boston: Little Brown; 1991, p. 441.
- Hofman MS, Ball DL, Mac Manus MP, et al. Let’s get serious: more accurate staging with consequent high management impact is not just stage migration. J Clin Oncol. 2013;31:819.
- Kahl BS, Yang DT. Follicular lymphoma: evolving therapeutic strategies. Blood. 2016;127:2055–2063.
- Trotman J, Luminari S, Boussetta S, et al. Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studies. Lancet Haematol. 2014;1:e17–e27.
- Radford J, Illidge T, Barrington S. PET-directed therapy for Hodgkin's lymphoma. N Engl J Med. 2015;373:392.
- Radford J, Illidge T, Counsell N, et al. Results of a trial of PET-directed therapy for early-stage Hodgkin’s lymphoma. N Engl J Med. 2015;372:1598–1607.
- Barrington SF, Kirkwood AA, Franceschetto A, et al. PET-CT for staging and early response: results from the response-adapted therapy in advanced Hodgkin lymphoma study. Blood. 2016;127:1531–1538.
- Carr R, Fanti S, Paez D, et al. Prospective international cohort study demonstrates inability of interim PET to predict treatment failure in diffuse large B-cell lymphoma. J Nucl Med. 2014;55:1936–1944.
- Meignan M, Cottereau AS, Versari A, et al. Baseline metabolic tumor volume predicts outcome in high-tumor-burden follicular lymphoma: a pooled analysis of three multicenter studies. J Clin Oncol. 2016. [Epub ahead of print]. doi: 10.1200/JCO.2016.66.9440.